DeğerQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTMSatış/genel/idari giderler251.25 M247.78 M259.79 M265.09 M275.68 M294.37 M1.09 BAraştırma ve geliştirme57.73 M59.06 M61.9 M63.41 M66.83 M65.79 M257.93 MFaaliyet karı261.69 M316.53 M373.05 M354.85 M315.61 M362.59 M1.41 BFaaliyet Dışı Gelir, Toplam———————Faiz gideri (aktifleştirilmiş faizler düşüldükten sonra)7.5 M7.67 M11.32 M10.65 M9.21 M7.74 M38.93 MFaaliyet Dışı Gelir (Faiz Giderleri Hariç)———————Olağandışı gelirler/giderler———————Vergi öncesi kar256.39 M310.08 M362.35 M344.77 M306.98 M355.44 M1.37 BKazançlardaki özsermayeler———————Vergiler40.24 M67.41 M68.36 M70.16 M58.79 M77 M274.31 MKontrol gücü olmayan/azınlık payı———————Vergi sonrası diğer gelirler/giderler———————Durdurulan faaliyetler öncesi net kar216.15 M242.68 M293.99 M274.61 M248.19 M278.45 M1.1 BDurdurulan faaliyetler———————Net kar216.15 M242.68 M293.99 M274.61 M248.19 M278.45 M1.1 BSeyreltme ayarlaması———————İmtiyazlı temettüler———————Adi hisse senedi sahiplerine düşen seyreltilmiş net kar216.15 M242.68 M293.99 M274.61 M248.19 M278.45 M1.1 BTemel hisse başına kazanç (Temel EPS)2.642.983.663.433.13.513.69Seyreltilmiş hisse başına kazanç (Seyreltilmiş EPS)2.622.963.633.43.093.4713.59Dolaşımdaki ortalama adi hisse senedi sayısı82.47 M81.32 M80.41 M80.1 M80.43 M79.65 M—Dolaşımdaki seyreltilmiş hisse senedi sayısı83.25 M81.92 M80.99 M80.67 M81.03 M80.16 M—FAVÖK291.82 M347.71 M405.88 M388.24 M349.43 M392.38 M1.54 BFVÖK258.11 M313.64 M370.11 M351.61 M310.7 M354.7 M1.39 BGelir maliyeti385.42 M375.05 M416.19 M423.5 M434.92 M422.02 M1.7 BSatılan malların diğer maliyeti———————Amortisman ve itfa (nakit akışı)33.71 M34.06 M35.77 M36.63 M38.72 M37.68 M148.8 M
IDEXX Laboratories, Inc. - Common Stock
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions.
IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.